23andMe Holding Co. (NASDAQ:ME) Q2 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Wade Walke - VP, IR Anne Wojcicki - Co-Founder, CEO, President & Director Steven Schoch - Chief Financial & Accounting Officer Kenneth Hillan - Head, Therapeutics Conference Call Participants Daniel Grosslight - Citigroup Operator Good day, ladies and gentlemen, and welcome to the 23andMe's Fiscal Year 2022 Second Quarter Earnings Call. [Operator Instructions]. As a reminder, this conference ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39587 23ANDME HOLDING CO. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporati ...

23andMe Holding Co. (NASDAQ:ME) Q1 2022 Earnings Conference Call August 13, 2021 11:00 AM ET Company Participants Wade Walke ??? Vice President-Investor Relations Anne Wojcicki ??? Co-Founder and Chief Executive Officer Steve Schoch ??? Chief Financial Officer Kenneth Hillan ??? Head-Therapeutics Conference Call Participants Daniel Grosslight ??? Citi Operator Good morning, and welcome to 23andMe???s Fiscal Year 2022 First Quarter Financial Results Conference Call. As a reminder, this call is being recorded ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended June 30, 2021 (Mark One) or ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 223 N. Mathilda Avenue Sunnyvale, California (Address of principal executive offices) (Zip Code) (650) 938-6300 (Registrant's ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39587 VG ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands N/A (State or other juri ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39587 VG ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands N/A (State or Other Jurisdiction of Incorporation or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39587 VG ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) | Cayman Islands | N/A | | --- | --- | | (State or ot ...